About the Conference
The new dates are September 28-29, 2016.
The Trans-Pacific Health Sciences Dialogue is a meeting for C-level biopharmaceutical industry executives and business development executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.
This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.
Take a look at some photos from the 2014 Trans-Pacific Health Sciences Dialogue!
In 2016, the Trans-Pacific Health Sciences Dialogue will be held at:
Joseph B. Martin Conference Center
at Harvard Medical School
77 Avenue Louis Pasteur
Boston, MA 02115
Who Should Attend
The Trans-Pacific Health Sciences Dialogue is an event for senior biopharmaceutical executives, KOLs, select industry advisors and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment.
Industry News from FiercePharmaAsia
- Long knives emerging in fight for TPP
The ink's not even dry yet on the Trans-Pacific Partnership announced this past Monday in Atlanta (and the specific details on many sections remain undisclosed), but the fight to get the 12-nation pact approved by the countries' respective legislatures and parliaments is already heating up.
Industry News from PharmAsia
- Permanent Indian Bar Against Glenmark’s Sitagliptin CopiesAn Indian court has permanently enjoined Glenmark from making and selling its generic version of Merck’s diabetes therapies Januvia and Janumet after the Indian firm was found to have infringed the sitagliptin patent.<img src="http://feeds.feedburner.com/~r/_PharmAsiaNews/~4/VFEXhKxdejg" height="1" width="1" alt="" />